Thursday, November 14, 2019 7:50:37 AM
Have Waited Several Years.. Whats a few more days, weeks, or months???
Fact is, Non of that matter & Posters Cant Post Whatever They Want; Be consistently negative, or Change course!!!
Non of that matter!!!!
The Company has been at this for a very long time for good reasons; All based on what they have learned along this uncharted pass (with hard work, brain powers, and unwavering dedications), while noticing competing forces (scientific or otherwise) that could derail them from reaching their intended destination!!
As they say, knowledge is Power & by relying on that principle, NWBO has remained focused on their objectives & have knowingly changed their course as they see fit!!!!
Literature now knows that about 95% of approved cancer drugs should be considered useless as they increase life by a mere 2-3 months while bankrupting the user & the other 5% might as well be considered failure as they just do slightly better. This tell us that if it was easy to succeed in bringing in a game changing novel way of cancer treatment, the success rate of those that have attempted it would have been considerably higher. And that's not considering side effects of these approved & unfortunately unsuccessful drugs!!!
Those who have followed the NWBO very closely, & have become fully aware of all of the competing forces, might have realized by now that the main & only focus of the company is to successfully take the ball over the finish line even if they have to crawl to do it so to remain unnoticed!!!!
IMO, Ducks are in a row & all that matters is the data reveal!!!
And the data will be revealed when the time is right such that an unequivocal success of all these long fight efforts could be unequivocally demonstrated!!!
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM